
Ceftriman SB 250mg/125mg Injection
Marketer
Aman Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftriman SB 250mg/125mg Injection
Ceftirim SB, a 250mg/125mg injectable combination drug, combats various bacterial infections by inhibiting microbial proliferation. Administer this medication strictly under medical guidance; complete the prescribed course, even with symptom improvement, to ensure efficacy. Premature cessation may reduce its effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects or allergic reactions (rash, itching, swelling, respiratory distress) immediately. Inform your physician about all concurrent medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential drowsiness. While generally safe for driving, refrain from operating vehicles if experiencing dizziness or sleepiness. Adequate rest, nutrition, and hydration aid recovery. Your doctor may order lab tests to monitor the medication's impact.
Uses of Ceftriman SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftriman SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftriman SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftriman SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ceftriman SB 250mg/125mg Injection works:
Ceftriman SB, a 250mg/125mg injectable formulation, unites the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a vital process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Ceftriman SB 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftriman SB, 250mg/125mg, is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Ceftriman SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftriman SB 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftriman SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should receive Ceftriman SB 250mg/125mg Injection cautiously, with potential dose modification. For patients with mild to moderate liver disease, dose alteration of Ceftriman SB 250mg/125mg Injection is unnecessary. Physician consultation is advised.
What if you forget to take Ceftriman SB 250mg/125mg Injection :
Omit a Ceftriman SB 250mg/125mg Injection dose? Seek medical advice immediately.
Facts to Know About Ceftriman SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
